Company Filing History:

9 out of 12,157

Bayer Aktiengesellschaft

patents

1 out of 378

Bayer Pharma Aktiengesellschaft

patents

Years Active: 1996-2011

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8034817 - Treatment of bacterial diseases of the respiratory organs (2011-10-11),

2. 6432948 - USE OF 7-(2-OXA-5,8-DIAZABICYLCO[4.3.0]NON-8-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDON CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF HELIOBACTER PYLORI INFECTIONS AND ASSOCIATED GASTRODUODENAL DISEASES (2002-08-13),

3. 6288081 - Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith (2001-09-11),

4. 6133260 - Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic (2000-10-17),

5. 6069160 - Heteroatom-containing benzocyclopentane-oxazolidinones (2000-05-30),

6. 5843967 - 6-membered nitrogen-containing heteroaryl-oxazolidinones (1998-12-01),

7. 5698574 - 5-membered heteroaryl-oxazolidinones (1997-12-16),

8. 5684023 - Benzofuranyl -and benzothienyloxazolidinones (1997-11-04),

9. 5627181 - 6-membered nitrogen-containing heteroaryl-oxazolidinones (1997-05-06),

10. 5529998 - Benzoxazolyl- and benzothiazolyloxazolidinones (1996-06-25),

Title: The Innovations of Harald Labischinski

Introduction

Harald Labischinski is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bacterial diseases. With a total of 10 patents to his name, Labischinski's work has had a profound impact on respiratory and gastrointestinal health.

Latest Patents

One of Labischinski's latest patents focuses on the treatment of bacterial diseases of the respiratory organs. This invention relates to inhalable quinolonecarboxylic acid derivative compositions designed for local control of diseases affecting the respiratory system, especially lung diseases. Another significant patent involves the use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and associated gastroduodenal diseases. This invention highlights the therapeutic potential of these compounds in addressing infections and related disorders.

Career Highlights

Throughout his career, Labischinski has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Labischinski has collaborated with notable colleagues such as Klaus Schaller and Hans-Otto Werling. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Harald Labischinski's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the treatment of bacterial diseases, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.